@article{L Laurenti_P Piccioni_M Tarnani_DG Efremov_A Fiorini_M Garzia_S Sica_2005, place={Pavia, Italy}, title={Low-dose intravenous alemtuzumab therapy in pretreated patients affected by chronic lymphocytic leukemia. A single center experience}, volume={90}, url={https://haematologica.org/article/view/3641}, DOI={10.3324/%x}, abstractNote={We report the efficacy and safety of intravenous low-dose alemtuzumab (10 mg three times weekly for 10 weeks) in 12 patients with relapsed or refractory chronic lymphocytic leukemia. Low-dose alemtuzumab induced significant responses in these patients (16% complete remission, 25% partial remission), with mild hematologic and extrahematologic side effects and a low rate of infections, even in the presence of long-lasting severe immunosuppression.}, number={8}, journal={Haematologica}, author={L Laurenti and P Piccioni and M Tarnani and DG Efremov and A Fiorini and M Garzia and S Sica}, year={2005}, month={Aug.}, pages={1143-1145} }